U. Prabhakar
Cancer Research · 2013
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom U. Prabhakar trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts U. Prabhakar overall
Papers from U. Prabhakar's perspective
Ordered by how strongly the researchers U. Prabhakar trusts endorse each paper. Same corpus, a different order for every researcher.
- Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. (Journal of Clinical Oncology)
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile (Science Translational Medicine)
- Delivering nanomedicine to solid tumors (Nature Reviews Clinical Oncology)
- Pathology: Cancer cells compress intratumour vessels (Nature)
- Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (Nature Medicine)
- Role of extracellular matrix assembly in interstitial transport in solid tumors. (Cancer Research)
- Angiogenesis in life, disease and medicine (Nature)
- Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. (Cancer Cell)
- Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors (Proceedings of the National Academy of Sciences of the United States of America)
- Tissue-penetrating delivery of compounds and nanoparticles into tumors (Cancer Cell)